Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Andrea K KewDarrell White

Abstract

Stem cell transplantation (SCT) is associated with complications that may necessitate intensive care unit (ICU) admission. The outcome for SCT patients requiring ICU admission has been reported to be poor. We describe the outcome of consecutive SCT patients admitted to the ICU at a single center. The study was a retrospective review of all patients at the Queen Elizabeth II Health Sciences Center who received an SCT between 1992 and 2001 and were subsequently admitted to the ICU. The primary outcome was overall survival at 12 months after ICU admission. There were 440 SCTs in the study period; 38 of these patients were admitted to the ICU on 42 separate occasions. The primary indication for ICU admission was respiratory failure. The probability of survival at 12 months was 21.6% (95% CI, 8.4%-34.9%). On multivariate analysis, the only statistically significant variable associated with decreased 12-month survival was vasopressor use. The probability of survival for patients receiving vasopressor support was 5% (95% CI, 0%-14.5%) at 30 days and 0% at 12 months, whereas the probability of survival for patients not receiving vasopressor support was 76.5% (95% CI, 56.3%-96.6%) at 30 days and 45.8% (95% CI, 21.5%-69.9%) at 12 months....Continue Reading

References

Mar 1, 1992·The American Review of Respiratory Disease·S W Crawford, F B Petersen
Jan 1, 1989·Critical Care Medicine·S J DenardoP E Bellamy
Jan 1, 1988·Intensive Care Medicine·C TorrecillaE Dominguez de Villota
Mar 1, 1988·The American Review of Respiratory Disease·S W CrawfordJ G Clark
Mar 24, 1994·The New England Journal of Medicine·J O Armitage
Sep 10, 1998·American Journal of Respiratory and Critical Care Medicine·K J PriceB S Andersson
May 16, 2000·Critical Care Medicine·A J HuaringaR E Champlin

❮ Previous
Next ❯

Citations

Apr 9, 2004·American Journal of Respiratory and Critical Care Medicine·Robert M KotloffStephen W Crawford
Sep 24, 2013·Bone Marrow Transplantation·R BenzG Stussi
Mar 17, 2010·QJM : Monthly Journal of the Association of Physicians·S McGrathM Ostermann
Feb 4, 2014·Critical Care Nursing Clinics of North America·Roberta Kaplow
Sep 22, 2012·Medicina clínica·Rosa Jannone ForésJuan Bonastre Mora
Aug 5, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Patricia JenkinsD Kathryn Tierney
Dec 1, 2009·Critical Care Clinics·Bekele Afessa, Elie Azoulay
Jan 20, 2015·Critical Care Medicine·Gagan KumarUNKNOWN Milwaukee Initiative in Critical Care Outcomes Research Group of Investigators
Feb 3, 2009·Clinics in Chest Medicine·John R McArdle
Jul 23, 2016·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Marion CornishRobert S Green
Oct 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ulas D BayraktarJoseph L Nates
Mar 7, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ulas D BayraktarJoseph L Nates
Feb 11, 2016·World Journal of Clinical Oncology·Ulas D Bayraktar, Joseph L Nates
Jun 21, 2017·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Kristen Lach, Sarah J Peterson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.